Datadog, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data Datadog, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	101	198	363	603	1,029	1,675	2,128	2,684	3,427
Cost of revenue	23.4	46.5	88.9	130	234	347	410	516	687
Gross profit	77.3	152	274	473	795	1,328	1,718	2,169	2,740
Research and development	24.7	55.2	111	211	420	752	962	1,153	1,548
Selling and marketing	44.2	88.8	147	214	299	495	609	757	956
General and administrative	11.4	18.6	35.9	62.8	94.4	139	180	205	280
Operating expenses	80.3	163	294	487	814	1,387	1,752	2,114	2,785
Operating income	-2.96	-11	-20.1	-13.8	-19.2	-58.7	-33.5	54.3	-44.4
Interest expense			0.03	30.4	21.1	16.5	6.3	7.07	11.1
Interest income						34.9	103	155	194
Other non-operating income	0.84	0.79	4.16	-8.45	0.73	2.23	-3.46	1.4	-12
Pre-tax income	-2.11	-10.2	-16	-22.2	-18.4	-38.1	60.2	204	127
Income tax	0.46	0.52	0.73	2.33	2.32	12.1	11.7	20.2	19.3
Net income	-2.57	-10.8	-16.7	-24.5	-20.7	-50.2	48.6	184	108
EBITDA	-0.76	-5.53	-8.54	0.73	-0.66	-31.7	2.14	103	4.83
EPS, basic	-0.04	-0.15	-0.12	-0.08	-0.07	-0.16	0.15	0.55	0.31
EPS, diluted	-0.04	-0.15	-0.12	-0.08	-0.07	-0.16	0.14	0.52	0.31
Shares, basic (weighted)	61.3	71	140	300	309	315	324	336	347
Shares, diluted (weighted)	61.3	71	140	300	309	315	350	359	363

Balance sheet

	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	60	53.6	597	225	271	339	330	1,247	401
Short-term investments			177	1,293	1,283	1,545	2,253	2,942	4,074
Receivables		55.8	102	163	269	400	509	599	741
Other current assets		8.77	19.2	23.6	24.4	27.3	41	67	90.2
Total current assets		122	904	1,718	1,871	2,344	3,178	4,911	5,382
Property, plant and equipment		21.6	32.7	47.2	75.2	125	172	227	338
Lease right-of-use assets			53	57.8	61.4	87.6	127	173	215
Goodwill	6.29	7.63	9.06	17.6	292	348	353	360	531
Intangible assets		1.29	1.44	2.07	15.7	16.4	9.62	3.71	15
Other non-current assets		8.6	17	17	19.9	24.4	23.5	24.1	36.6
Total assets		180	1,038	1,890	2,381	3,005	3,936	5,785	6,644
Accounts payable		12.6	15.4	21.3	25.3	23.5	87.7	108	149
Accrued liabilities		6.94	12.5	20	16.4	25
Deferred revenue		69.3	134	205	372	543	766	962	1,194
Total current liabilities		112	200	298	529	760	1,003	1,863	1,591
Lease liabilities			48.5	51.4	52.1	76.6	138	197	256
Other non-current liabilities		1.36	2.61	4.26	9.41	6.23	6.09	9.38	11.9
Total liabilities		115	256	933	1,340	1,594	1,911	3,071	2,912
Paid-in capital		30.8	906	1,103	1,197	1,625	2,181	2,689	3,579
Retained earnings		-107	-124	-148	-152	-202	-154	30	138
Other comprehensive income		0.03	0.13	2.29	-3.83	-12.4	-2.22	-4.7	15.4
Shareholders' equity	-75.7	-76	782	957	1,041	1,411	2,025	2,714	3,732
Total equity	-75.7	-76	782	957	1,041	1,411	2,025	2,714	3,732
Total liabilities and equity		180	1,038	1,890	2,381	3,005	3,936	5,785	6,644
Shares outstanding		78.2	0

Cash flow statement

	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-2.57	-10.8	-16.7	-24.5	-20.7	-50.2	48.6	184	108
Depreciation and amortization	2.2	5.5	11.6	14.5	18.5	27	35.6	48.5	49.2
Stock-based compensation	3.07	5.24	19	74.4	164	363	482	570	751
Deferred income tax	-0.12	0.09	-0.36	-0.04	-0.04	-0.39	-0.89	-2.4	-1.24
Change in receivables	-19.3	-25.3	-47.5	-64.2	-107	-136	-122	-104	-157
Change in payables	4.65	7.24	2.48	6.54	3.08	-1.29	57.8	25.6	36.6
Cash from operations	13.8	10.8	24.2	109	287	418	660	871	1,050
Capital expenditures	-2.35	-9.66	-13.3	-5.42	-9.96	-35.3	-27.6	-34.7	-49.6
Acquisitions	-4.96	-1.62	-2.14	-2.36	-227	-45.9	-12.5	-7.13	-118
Purchases of investments			-177	-1,795	-1,126	-1,414	-2,558	-2,653	-3,600
Sales and maturities of investments			0	507	1,047	1,138	1,865	2,019	2,488
Cash from investing	-12.8	-17.5	-202	-1,153	-274	-385	-731	-737	-1,334
Stock issued	0.46	7.78	7.9	16	14.9	10	20.9	7.44	6.44
Cash from financing	0.46	7.78	714	670	34.9	36	58.3	787	-572
Exchange rate effect	-0.05	0.05	-0.02	0.78	-1.99	-1.94	1.18	-4.2	11.2
Net change in cash	1.48	1.2	536	-372	45.8	67.8	-11.9	917	-846
Free cash flow	11.5	1.17	10.9	104	277	383	632	836	1,001
Income taxes paid	0.04	0.04	0.14	0.41	1.49	1.6	16.5	21	17.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $268.13 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	79.5%	Gross profit / revenue.
Operating margin	0.4%	Operating income / revenue.
EBITDA margin	2.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.0%	Pre-tax income / revenue.
Net margin	4.5%	Net income / revenue.
FCF margin	29.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	31.0%	Cash from operations / revenue.
Effective tax rate	11.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	4.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.4%	Net income / average total assets.
Return on invested capital (ROIC)	0.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	43.7%	Research and development expense / revenue.
Stock-based pay / revenue	20.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.2%	Capital expenditures / revenue.
D&A / revenue	1.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	27.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	26.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	41.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	26.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	27.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	42.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-181.7%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-95.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y	46.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-41.4%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-40.4%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	20.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	35.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	57.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	19.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	37.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	57.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	37.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	38.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	31.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	14.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	30.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	28.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	4.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	3.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.20x	Current assets / current liabilities.
Quick ratio	3.10x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	2.66x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	42.1%	Total liabilities / total assets.
Interest coverage	1.43x	Operating income / interest expense.
Working capital	$4.13B	Current assets - current liabilities.
Goodwill and intangibles / assets	9.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	$3.64B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.53x	Revenue / average total assets.
Fixed asset turnover	9.68x	Revenue / average property, plant and equipment.
Receivables turnover	4.79x	Revenue / average receivables.
Days sales outstanding	76 days	365 x average receivables / revenue.
Days payables	141 days	365 x average accounts payable / cost of revenue.
FCF conversion	665.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	3.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.48	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$10.69	Revenue / diluted weighted shares.
FCF per share	$3.19	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.31	Cash from operations / diluted weighted shares.
Book value per share	$11.77	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$9.80	Tangible book value / shares outstanding.
Cash per share	$13.44	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$96.28B	Share price x shares outstanding.
Enterprise value	$91.29B	Market cap + total debt - cash - short-term investments.
P/E	542x	Market cap / net income. Only when net income is positive.
P/S	24.3x	Market cap / revenue.
P/B	22.0x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	26.5x	Market cap / tangible book value, when positive.
P/FCF	81.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	78.3x	Market cap / cash from operations, when positive.
EV/Sales	23.0x	Enterprise value / revenue.
EV/EBIT	5,591x	Enterprise value / operating income, when both are positive.
EV/EBITDA	1,166x	Enterprise value / EBITDA, when both are positive.
EV/FCF	77.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.2%	Free cash flow / market cap.
Earnings yield	0.2%	Net income / market cap (the inverse of P/E).

What was Datadog, Inc.'s revenue in fiscal 2025?

Datadog, Inc. reported revenue of $3.43B for fiscal 2025, 27.7% higher than the year before.

Was Datadog, Inc. profitable in fiscal 2025?

Yes. Net income was $107.7M, a net margin of 3.1%.

How much free cash flow did Datadog, Inc. generate in fiscal 2025?

Cash from operations of $1.05B minus capital expenditures of $49.6M left free cash flow of $1.00B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Datadog, Inc.